Related Experiment Video
Updated: Feb 17, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells
Dan-Dan Xu1, Xiao-Feng Li2, Yu-Huan Li2
1Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Pharmacy Department, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
Abstract:
TIPE2, the tumor necrosis factor (TNF)-α-induced protein 8-like 2 (TNFAIP8L2), plays an important role in regulating inflammation and immune homeostasis. Recent studies discovered that TIPE-2 involved in the development of several tumors and other proliferative diseases. The purpose of this study was to explore the function of TIPE-2 in the activation and proliferation in HSC-T6 cells. Our study showed low expression of TIPE-2 in primary HSCs from CCl4-treated mice and activated HSC-T6 cells. Functionally, over-expression of TIPE-2 by GV141-TIPE-2 hindered the HSC-T6 cells activation and proliferation and expressions of β-Catenin, Cmyc, Cyclin D1. However, inhibition TIPE-2 expression by TIPE-2 siRNA showed the opposite effect. These observations revealed that TIPE-2 held a protective effect on liver fibrosis and could be a potential therapeutic target.
Insights
Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) protects against liver fibrosis. Overexpressing TIPE2 inhibits hepatic stellate cell activation and proliferation, suggesting its therapeutic potential.
Area of Science:
- Hepatology
- Immunology
- Cell Biology
Background:
- TIPE2 (TNFAIP8L2) regulates inflammation and immune homeostasis.
- TIPE2 is implicated in tumor and proliferative disease development.
- Hepatic stellate cells (HSCs) are key players in liver fibrosis.
Purpose of the Study:
- To investigate the role of TIPE2 in HSC-T6 cell activation and proliferation.
- To determine TIPE2's impact on liver fibrosis development.
Main Methods:
- Assessed TIPE2 expression in primary HSCs and HSC-T6 cells.
- Utilized GV141-TIPE-2 for TIPE2 overexpression.
- Employed TIPE-2 siRNA for TIPE2 inhibition.
- Monitored HSC activation, proliferation, and expression of β-Catenin, Cmyc, and Cyclin D1.
Main Results:
- Low TIPE2 expression observed in CCl4-treated mice HSCs and activated HSC-T6 cells.
- TIPE2 overexpression suppressed HSC-T6 cell activation, proliferation, and key protein expressions.
- TIPE2 inhibition promoted HSC activation and proliferation.
Conclusions:
- TIPE2 exhibits a protective role in liver fibrosis.
- TIPE2 acts as an inhibitor of HSC activation and proliferation.
- TIPE2 represents a potential therapeutic target for liver fibrosis.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Tissue Renewal without Stem Cells
However, failure of such a system...

